688105 fundamentals

An in-depth look to NANJING VAZYME BIOTECH CO LTD operating, investing, and financing activities

688105 free cash flow for Q1 25 is -53.36 M CNY. For 2024, 688105 free cash flow was -31.98 M CNY and operating cash flow was 42.92 M CNY.

Q1 '21

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Q1 '25

Cash from operating activities

Cash from investing activities

Cash from financing activities

Currency: CNY